Enanta Pharmaceuticals (ENTA) Q4 2024 Earnings

25NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.58
-1.41
-1.24
-1.07

Details

Expected EPS
-1.160749
Actual EPS
-1.36
Surprise EPS
-0.2
Surprise Percent
+17.17%

Description

Enanta Pharmaceuticals (ENTA) has reported earnings of -1.36 per share for Q4 2024.

0 Comments

Share your thoughts